Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) Cost of Revenue (2017 - 2025)

Catheter Precision (VTAK) has disclosed Cost of Revenue for 9 consecutive years, with $18000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Cost of Revenue rose 80.0% to $18000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $54000.0, a 42.11% increase, with the full-year FY2024 number at $42000.0, up 40.0% from a year prior.
  • Cost of Revenue was $18000.0 for Q3 2025 at Catheter Precision, up from $14000.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $2.4 million in Q2 2021 to a low of -$1.6 million in Q3 2021.
  • A 5-year average of $105529.4 and a median of $11000.0 in 2024 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: crashed 390.14% in 2021, then skyrocketed 128.57% in 2024.
  • Catheter Precision's Cost of Revenue stood at $347000.0 in 2021, then plummeted by 93.08% to $24000.0 in 2022, then tumbled by 70.83% to $7000.0 in 2023, then skyrocketed by 57.14% to $11000.0 in 2024, then skyrocketed by 63.64% to $18000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Cost of Revenue are $18000.0 (Q3 2025), $14000.0 (Q2 2025), and $11000.0 (Q1 2025).